Method for forecasting arrival of drug inside diseased tissue
AssigneesKonica Minolta, Inc., National Cancer Center
InventorsAkinobu HAMADA, Mitsuhiro HAYASHI
Life of this patent
Estimating the term…
Abstract
Provided is a method for forecasting arrival of a drug inside a diseased tissue before administration of the drug to a patient. The present invention includes a method for forecasting, in a diseased tissue in which a biomarker A derived from a diseased cell is expressed, arrival of a drug targeting the biomarker A inside the diseased tissue, the method including a step B for acquiring information on expression of a biomarker B derived from a non-diseased cell adjacent to or close to the diseased cell.
Claims20
A method for forecasting,
- in a diseased tissue in which a biomarker A derived from a diseased cell is expressed,
- arrival of a drug targeting the biomarker A inside the diseased tissue, the method comprising
- (B) acquiring information on expression of a biomarker B derived from a non-diseased cell adjacent to or close to the diseased cell.
A method for forecasting arrival of a drug targeting a biomarker A derived from a diseased cell in a diseased tissue inside the diseased tissue from both of information on expression of the biomarker A and information on expression of a biomarker B derived from a non-diseased cell adjacent to or close to the diseased cell, the method comprising:
- (A) acquiring the information on expression of the biomarker A;
- and (B) acquiring the information on expression of the biomarker B.
An activity regulator of a biomarker B derived from a non-diseased cell adjacent to or close to a diseased cell.
Dependencies are inferred from the claim text.